Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
AHK-Cu: Evidence Summary
Evidence summary for AHK-Cu across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to AHK-Cu overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Hair growth (androgenetic alopecia) | Tier D | 0 | Single ex vivo study only — no in vivo human data |
| Skin rejuvenation | Tier D | 0 | No studies; claims extrapolated from GHK-Cu data |
References (2)
- Effects of AHK-Cu on hair follicle elongation and dermal papilla cell proliferation — Philp D, et al. . Journal of Investigative Dermatology (2007)
- The effect of tripeptide-copper complex on human hair growth in vitro. — Pyo HK, Yoo HG, Won CH, et al. . Archives of pharmacal research (2007) PMID: 17703734